Home | Volume 44 | Article number 7


A cross-sectional study on the prevalence of HIV and hepatitis B virus co-infection among students of a tertiary institution in Ekiti State, Southwest Nigeria

A cross-sectional study on the prevalence of HIV and hepatitis B virus co-infection among students of a tertiary institution in Ekiti State, Southwest Nigeria

Olakunle Amos Ojerinde1, Stephen Kayode Simpa Ojo2, Uchenna Linda Udewena2, Seye Julius Oladeji2,&


1University Medical Centre, Federal University Oye-Ekiti, Ekiti State, Nigeria, 2Drug Discovery and Infectious Diseases Research Group, Department of Microbiology, Federal University Oye-Ekiti, Ekiti State, Nigeria



&Corresponding author
Seye Julius Oladeji, Drug Discovery and Infectious Diseases Research Group, Department of Microbiology, Federal University Oye-Ekiti, Ekiti State, Nigeria




Nigeria aims to eradicate public-health threats such as HIV/AIDS and hepatitis B virus (HBV) by 2030. However, to achieve the short- and medium-term response target, and end the epidemic by 2030, there is the need to monitor and estimate the population level of HIV and HBV epidemic trends to boost the country's strategic framework's chances of success. Hence, we uncovered the prevalence of HIV and HBV among full-time, newly admitted undergraduate university students in Southwestern Nigeria between 2015 and 2017. In this regard, 4 ml of blood samples was collected from each subject into Ethylene Diamine Tetraacetic Acid (EDTA) bottles and were allowed to stand for one hour. Samples were allowed to separate into plasma and corpuscles on the bench. HIV screening was done using an immunochromatographic method via a highly sensitive kit DETERMINE® (Abbott Diagnostic Division, Netherlands) and were later confirmed using Enzyme Linked Immunosorbent Assay (ELISA) Uni-Gold® manufactured by Trinity Biotech Plc, Ireland. HBV screening was carried out using an immunoassay method for the detection of the hepatitis B surface antigen (HBsAg). Out of the 4,623 subjects recruited, 2,545 were male while 2,078 were female. The overall prevalence of HIV was found to be 0.13% while that of HBV was 2.23%. Conclusively, although HIV was found to be less prevalent among the study as compared to HBV; however, the higher transmission propensity of HBV necessitates even more urgent efforts to eradicate the infectious diseases.



Introduction    Down

In the context of HIV/AIDS, educational institutions are supposed to impart to students the knowledge, abilities, and attitudes that encourage safe behaviours so that they can prevent HIV infection [1]. Nigeria is one of the African countries with no formal HIV/AIDS policies in place at tertiary institutions [2]. However, it is crucial to emphasize that efforts to eradicate AIDS require higher institutions to carry out both social and moral duties. Hence, in order to establish control over the threat, creating an institutional policy for addressing AIDS is a step in the right direction [2]. According to the 2017 revision of the World Population Prospects, the total Nigerian population was estimated at 185,989,640 in 2016, with adolescents and young adults (aged 15-39 years) accounting for the majority of this population. More importantly, these people are more socially active, which makes them more vulnerable to infectious diseases like HIV and HBV [3].

Unfortunately, the number of HIV tests and counselling sessions provided in Nigeria has remained below the advised level over time. In light of this, women aged 15 to 49 are more than twice as likely to be living with HIV than males (1.9% vs 0.9%), despite Nigeria's overall HIV prevalence among people aged 15 to 49 being 1.4%. The disparity in the prevalence of HIV in women and men is largest among younger persons, with young women aged 20 to 24 years more than three times as likely to be infected as young males in the same age range. According to the most recent rankings, Nigeria is one of the nations with the most unequal power distributions in the world, coming in at number 122 out of 144 nations for the size of its "gender gap". In the context of gender power disparities, women commonly experience challenges choosing their own sexual partners, using contraception, deciding how many children to have, and managing their own healthcare, all of which increase their risk of contracting HIV [3].

While it has been shown that blood transfusion and heterosexual transmission account for around 80% and 5% of HIV infections, respectively, mother-to-child transmission, needle sharing, and scarification, to mention a few, account for the remaining 15% [4]. The behavioral attitude of Nigerians in regard to sex is the main cause of the epidemic. Additionally, high levels of poverty, harmful traditional practices, high stigma and patient discrimination, low levels of education, high levels of sexually transmitted infections, mother-to-child transmission, widespread high-risk sex, low risk perception, high rates of sexually transmitted infections (STIs), wife hospitality, spouse sharing, and polygamy are some of the observed factors causing the pandemic to spread [5].

Despite the introduction of universal HBV vaccination and effective antiviral therapy, the estimated overall sero-prevalence of HBV surface antigen remains high in Nigeria at 8.1%. HBV is very similar to HIV in the ways it is transmitted: through direct blood to blood contact and through sexual activity. However, blood levels of HBV are much higher than for HIV, making the virus much easier to transmit in certain situations. Additionally, despite the fact that HBV infection is widespread in Nigeria, little is known about the virus's epidemiology among young people and student populations in spite of the importance of this information for creating successful intervention programs. Before any clinical signs appear, a person may have HBV infection for 30 years or more. Sero-conversion from HBeAg to HBeAb and serum elimination of HBV deoxyribonucleic acid (DNA) are linked to illness remission [6].

To this end, while efforts are currently being made in Nigeria to eradicate HIV and HBV infections, it is undoubtedly vital to track and estimate the population level of HIV and HBV epidemic trends in order to boost the country's strategic framework's chances of success. As a result, this study uncovered the prevalence of HIV and HBV among the newly admitted students at a tertiary university in southwestern Nigeria, taking into account the significant role played by the university students in the spread of these infectious diseases across the country.



Methods Up    Down

Study population: a total of 4,623 samples were collected from newly admitted students of the Federal University Oye-Ekiti, Ekiti State, South-West Nigeria over a period of about 3 years (2015-2017). Of the 4,623 students, 2,268 were females and 2,355 were males of age range of 15-39 years.

Inclusion/exclusion criteria: these include being a full-time and newly admitted undergraduate student at the Federal University Oye-Ekiti State and willingness to volunteer a blood sample.

Study design: this cross-sectional survey included only first-year male and female students at Federal University Oye-Ekiti. After obtaining the participants' consent, blood samples were taken from willing students for testing. The collecting point was the university health center.

Sample collection and preparation: venepuncture method was used to collect 4 ml of whole blood from the participating undergraduates into 1.5 mg/mL EDTA (Ethylene Diamine Tetraacetic Acid). Thereafter, the samples were allowed to separate into plasma and corpuscles.

Sample testing

Human immunodeficiency virus (HIV) screening; baseline testing: in accordance with the serial algorithm adopted for the study and recommended by Amechi et al. [7], all samples were initially screened for the presence of HIV types 1 and 2 antibodies using an immunochromatographic method via the DETERMINE® (Abbott Diagnostic Division, Netherlands) highly sensitive rapid test kit, as described by Daramola et al. [8] and Amechi et al. [7]. After removing the test pouch's protective foil cover, 50 L of plasma was poured onto the sample-pad. The result was read in accordance with the manufacturer's instructions after allowing enough time for the plasma to go through the control and test windows. ELISA Immunosorbent Assay (EIA): The EIA method, which was able to identify and confirm the presence of HIV antibodies, was used to confirm the true positivity of all the participants who tested positive at baseline screening. This was accomplished utilizing Uni-Gold®, a product of Ireland's Trinity Biotech Plc.

Hepatitis B surface antigen test: hepatitis B surface antigen was detected by using an immunoassay technique (HBsAg). After removing the test pouch's protective foil cover, 50 L of plasma was poured onto the sample-pad. The result was read in accordance with the manufacturer's instructions after allowing enough time for the plasma to go through the control and test windows.

Statistical analysis: this was carried out using SPSS version 16, and the results or outcomes were shown in figures, tables, and graphs. The prevalence of HBsAg and HIV viral infections were determined from the proportion of seropositive individuals in the population under consideration and expressed as a percentage.



Results Up    Down

The subjects comprised of a total of 4,623 participants having 2,545 (55.05%) males and 2,078 (44.95%) females (Table 1). A total of 1 (0.02%) subject was within 10-14 years; 2,897 (62.67%) subjects were within 15-19 years; 1,493 (32.30%) were within 20-24 years, 206 (4.46%) were within 25-29 years while 16 (0.35%) and 10 (0.22%) were within the 30-34 and 35-39 years, respectively (Figure 1). Of the 6 HIV positive participants, 2 (33.33%) were within the age range of 15-19 years while 4 (66.67%) were within the age range of 20-24 years. The age range distribution of HBV positive subjects within 15-19 years were 52 (53.61%), 43 (44.33%) were within 20-24 years, and 2 (2.06%) within 25-29 years (Figure 2). Only 1 female subject was HIV positive in 2015; 2 females and 1 male in 2016, and 2 females in 2017. However, among the HBV positive subjects, 2 males and 3 females were tested positive in 2015, 57 males and 23 females in 2016, and 10 males and 8 females in 2017. This study revealed high prevalence of HBV among student population especially with male subjects as compared to HIV. Total HIV prevalence from the subjects was 0.13% while total HBV prevalence was 2.23% (Figure 3).



Discussion Up    Down

Studies have shown that most university students do not know their HIV and HBV status, and this increase the chances of infection and spread. Hepatitis B virus and HIV share a common risk factor and common mode of transmission, so it is rationale to study the prevalence of these two together. Reports from Isa et al. [9] (9.2%), Alo et al. [10] (15.5%), Tula and Iyoba [11] (31.5%), Pennap et al. [12] (11.5%), Olalekan [13] (6.2%) suggests that HBV is endemic in Nigeria and also within Nigerian tertiary institutions. In this present study, results showed a higher prevalence of HBV (4.62%) for the year 2016 compared to the year 2015 (0.57%) and year 2017 (0.89%). The total HBV prevalence for the 3 years is (2.23%) which means that the study population has intermediate endemicity (2%-7%) of HBV.

This result correlates with that of Akinbolaji et al. [14], Simidele et al. [15], Mboto and Edet [16], Enitan et al. [17] and Olalekan [13], who also reported moderate endemicity of 6.16%, 4.5%, 4.7%, 1.5% and 6.2%, respectively and much lesser than the reports of Aminu et al. [18], Musa et al. [19], Olayinka et al. [20], Pido et al. [21], Mohammed et al. [22], Ndako et al. [23], who reported high endemicity of 12.5%, 13.6%, 12.2%, 11.0%, 9.7%, 18.4%, respectively. The intermediate (2.23%) prevalence of HBsAg obtained in this study suggests that hepatitis B is somewhat common among students in the campus. Hepatitis B virus can be transmitted via contact with all bodily fluid (including saliva, semen, sweat, breast milk, tears, urine, vaginal secretions, and faeces), and by frequent and prolonged close personal contact with an infected person [18].

This study also showed that HBV is more common in male than females, which correlates with the reports of Akinbolaji et al. [14], Aminu et al. [18], Lado et al. [24], Enitan et al. [17], and Simidele et al. [15] but contrasts with the findings of Mboto and Edet [16], and Ndako et al. [25]. This could be due to disparity in sample size, sample population and the varying levels of engagement in the risk predisposing practices across populations and communities. Uneke et al. [26] suggested that both sexes are equally susceptible to HBV infection while gender may not necessarily be an important epidemiological determinant of HBV infection. Conversely, in the study conducted by Mehmet et al. [27], higher prevalence was observed among male subjects as compared to female subjects in both rural and urban areas. The authors also noted that male sex was an important risk factor for HBsAg positivity, which is consistent with the findings of the present study. Additionally, the reason for the high HBV infection rate among the males may be due to risky habits such as multiple sexual partnership and poor educational background which affect enlightenment and promote the transmission of the virus. Educational background may assist at prevention of transmission by enlightenment strategies [25].

Furthermore, the highest prevalence was found within the age group 15-19 years followed by 20-24 years, which suggests that most of these subjects may have acquired the infection though risky lifestyles or behaviours. Testing and treatment of existing infection does a substantial impact as vaccinating older age group has negligible sustained effort in curbing increasing HBV infection as reported by McNaughton et al. [28]. Nigeria is one of the African countries with no formal HIV/AIDS policies in place at tertiary institutions [2]. Although there is information on the prevalence of HIV in various states and among different populations in Nigeria, there is however paucity of data on the prevalence among students of tertiary institutions. The HIV/AIDS situation in the university by the nature of their establishment, universities should take the threat posed by HIV/AIDS seriously without being prompted [29]. For a start, their principal clients are students, most of whom are in the 19-30 years age group. This is the age range within which HIV infection normally peak in most countries and so the need to limit its spread is of paramount importance. Generally, half of all those who become infected with HIV are young people under age 25.

In this study however, the prevalence of HIV infection among the university newly admitted students is quite low (0.13%) which is in line with the overall prevalence of less than 1% reported according to the National HIV/AIDS Indicator and Impact Survey [30] in the state. This very low prevalence of HIV may be because the study populations are freshers, which translates that most, or a good number of them have been staying under the watchful eyes of their parents or wards and so there is no such liberty to engage in high-risk behaviours that may expose them to the virus. The prevalence of HIV in this study conforms with that of Gayle et al. [31] (0.2%) but deviates a little bit from that reported by De Beer et al. [32] (1.8%) among students of Federal University in Namibia, and that of Mengistu [33] (2.5%). In addition, universities offer conditions ideal for the spread of HIV. Being a “captive” population, they contain a pool of HIV infected people [29]. Multiple sexual partnership is also likely on university campuses. Furthermore, partner mixing is another likely feature as students alternate between different sets of sexual partners during vacation and during academic sessions. The liberal atmosphere on university campuses is an added dimension to the whole episode. Some students may be enjoying independence from the watchful eyes of their parents for the first time.

This study has significant implications for achieving millennium development goals 4, 5, and 6 related to HIV in Nigeria and other sub-Saharan countries. There is a potential for an increased trend if adequate HIV services are not provided in institutions. Differences in sample populations between the studies may account for the variation in findings [9].



Conclusion Up    Down

Ensuring that youths are not infected is the greatest strategy for preventing the spread of HIV and HBV in tertiary institutions. The stigmatization associated with HIV/AIDS and the usual fear in going for the HIV test necessitates adequate advocacy and sensitization through the use of different IEC materials and media. Furthermore, it is necessary to include sex education among the first-year general studies courses to enlighten new students on issues on HIV/AIDS and other sexually transmitted diseases such as HBV and on the importance of HIV and HBV testing.

What is known about this topic

  • Nigeria is one of the African countries with no formal HIV/AIDS and HBV policies in place at tertiary institutions;
  • Youths, including university students orchestrate immense roles in the spread of HIV and HBV in Nigeria;
  • In recent years, Nigeria has been pragmatic about eliminating HIV and HBV in the country with little or no information on the epidemic trends of the infectious diseases amid her citizens.

What this study adds

  • We uncovered the prevalence of HIV and HBV among full-time newly admitted undergraduate student over a period of about 3 years;
  • This study has significant implications for achieving millennium development goals 4, 5, and 6 related to HIV and HBV in Nigeria and other sub-Saharan countries.



Competing interests Up    Down

The authors declare no competing interests.



Authors' contributions Up    Down

The research idea was conceptualized and designed by Olakunle Amos Ojerinde and Stephen Kayode Simpa Ojo; data acquisition, draft preparation, writing and analysis were carried out by Olakunle Amos Ojerinde, Stephen Kayode Simpa Ojo, Uchenna Linda Udewena and Seye Julius Oladeji; final review and editing were done by Olakunle Amos Ojerinde, Stephen Kayode Simpa Ojo, Uchenna Linda Udewena and Seye Julius Oladeji. All the authors read and approved the final version of this manuscript.



Acknowledgments Up    Down

We express our sincere gratitude to the students for consenting to participate in this study. Also, we thank the management of Federal University Oye-Ekiti, Nigeria for allowing us to use the University Health Centre and the Microbiology Research Laboratory for conducting the study.



Table and figures Up    Down

Table 1: distribution of total subjects by gender

Figure 1: distribution of total subjects by age brackets

Figure 2: distribution of HIV and HBV positive subjects by age group

Figure 3: distribution of HIV and HBV positive subjects by gender



References Up    Down

  1. Nom AUT. Combating HIV/AIDS epidemic in Nigeria: Responses from National Open University of Nigeria (NOUN). The International Review of Research in Open and Distributed Learning. 2007;8(3):1-21. Google Scholar

  2. Saint W. Crafting institutional responses to HIV/AIDS: guidelines and resources for tertiary institutions in sub-Saharan Africa. Africa Region Human Development Working Paper Series. 2004;14. Google Scholar

  3. National Agency for the Control of AIDS. Revised National HIV and AIDS Strategic Framework 2019-2021: Future Directions For the HIV/AIDS response in Nigeria. 2019.

  4. Ross-Larson CMB. Human Development Report, United Nations Development Programme. 2004;38.

  5. Eze JI. Modelling HIV/AIDS Epidemic in Nigeria. University of Glasgow. 2009. Google Scholar

  6. Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep. 2006 Dec 8;55(RR-16):1-33; quiz CE1-4. PubMed

  7. Amechi BO, Osagie RN, Chikwendu CI. Evaluation of False Positivity and Cross Reactivity in the Investigation of Human Immunodeficiency Virus Antibodies. International Journal of Community Research. 2012;1:54-59. Google Scholar

  8. Daramola GO, Oluyege AO, Edogun HA, Ojerinde AO, Olofinbiyi BA, Ajayi AO et al. Prevalence of Antibodies to HIV among Students of Select Tertiary Schools in Two Southwest States, Nigeria. J Biosci Med (Irvine). 2017;5(8):83-96. Google Scholar

  9. Isa I, Aminu M, Abdullahi SA, Sani MA, Esona MD. Seroprevalence of hepatitis B virus in a tertiary institution in North Western Nigeria. African Journal of Microbiology Research. 2015;9(3):171-9. Google Scholar

  10. Alo MN, Alhassan HM, Saidu AY, Ugah UI, Abdulahi H. Seroprevalence of hepatitis B surface antigen (HBsAg) among the medical students of Usmanudanfodiyo University, Sokoto, Sokoto State, Nigeria. Eur J Exp Biol. 2013;3(3):666-671.

  11. Tula MY, Iyoha O. A cross-sectional study on the seroprevalence of HBsAg among apparently healthy students of a tertiary institution in North-eastern Nigeria. Int J Trop Dis Health. 2015;7(3):102-108.

  12. Pennap GR, Nwachukwu O, Ishaleku D, Ombugadu RJ. Hepatitis B virus carriage among students of a Nigerian Tertiary Institution: a cohort of eligible blood donors. Res J Med. 2011;5:903.

  13. Olalekan AW. Prevalence and risk factors for hepatitis B and C among sexually active undergraduates in southwestern Nigeria. Ann Trop Med Public Health. 2015;8(6):235-40. Google Scholar

  14. Akinbolaji TJ, Adekoya-Benson T, Akinseye FJ, Odeyemi FA, Adegeye FO, Ojo OI. Prevalence of Hepatitis B Virus and Hepatitis C Virus Co-Infections among Ekiti People in South-Western Nigeria. International Journal of Health Sciences and Research. 2015;5(3):121-6.

  15. Simidele OM, Oladimeji A, Joseph AA, Aduayi V, Samuel NI. Burden of Hepatitis B Viral Infection among Workers in a Tertiary Health Institution in Southwestern Nigeria. Open Journal of Medical Microbiology. 2018;8(4):85-97. Google Scholar

  16. Mboto CI, Edet EJ. Prevalence and risk factors of hepatitis B virus infection among students in University of Uyo. International Journal of Modern Biology and Medicine. 2012;2(2):101-111.

  17. Enitan S, Adebola O, Adejumo E, Itodo G, Ileoma E, Oluremi A et al. Prevalence of Hepatitis B and C Virus Infection among Students of a Private Tertiary Institution in South-Western Nigeria. Intl J of Trop Dis & H. 2019;36(3):1-15. Google Scholar

  18. Aminu M, Okachi EE, Abubakar SM, Yahaya A. Prevalence of hepatitis B virus surface antigen among healthy asymptomatic students in a Nigerian University. Ann Afr Med. 2013;12(1):55-56. PubMed | Google Scholar

  19. Musa BM, Bussell S, Borodo MM, Samaila AA, Femi OL. Prevalence of hepatitis B virus infection in Nigeria, 2000-2013: a systematic review and meta-analysis. Niger J Clin Pract. 2015;18(2):163-172. PubMed | Google Scholar

  20. Olayinka AT, Oyemakinde A, Balogun MS, Ajudua A, Nguku P, Aderinola M et al. Seroprevalence of hepatitis B infection in Nigeria: a national survey. Am J Trop Med Hyg. 2016;95(4):902-907. PubMed | Google Scholar

  21. Pido B, Kagimu M. Prevalence of hepatitis B virus (HBV) infection among Makerere University medical students. Afr Health Sci. 2005;5(2):93-98. PubMed | Google Scholar

  22. Mohammed HI, Pennap GR, Oti VB, Adoga MP. Markers of hepatitis B virus infection in a subset of young people in central Nigeria. Scientific African. 2019;5:e00121. Google Scholar

  23. Ndako JA, Nwankiti OO, Echeonwu GO, Junaid SA, Anaele TJ, Anthony TJ. Studies on prevalence and risk factors for hepatitis B surface antigen among secondary school students in north-central Nigeria. S J Biomed Res. 2011;3(3):163-168. Google Scholar

  24. Lado ZY, Ogbaga CC, Nwagbara OF. Epidemiology of hepatitis B viral infection among students and non-teaching (casual) staff of Nile University of Nigeria: a 2017 study. J Pub Health Epidemiol. 2018;10(3):77-86. Google Scholar

  25. Ndako JA, Ojo S, Dojumo VT, Fajobi VO, Ifeanyi I, Akinwumi JA et al. Sero-Epidemiological Analysis of Hepatitis B Virus Infection among Apparently Healthy Young Adults in Omuaran-Community. International Journal of Pathogen Research. 2020;4(4):31-38. Google Scholar

  26. Uneke CJ, Ogbu PU, Anyanwu GI, Njoku MO, Idoko JH. Prevalence of hepatitis B surface antigen among blood donors and HIV-infected patients in Jos, Nigeria. Mem Inst Oswaldo Cruz. 2005;100(1):13-16. PubMed | Google Scholar

  27. Mehmet D, Meliksah E, Serif Y, Gunay S, Tuncer O, Zeynep S. Prevalence of hepatitis B infection in the southeastern region of Turkey: comparison of risk factors for HBV infection in rural and urban areas. Jpn J Infect Dis. 2005;58(1):15-9. PubMed | Google Scholar

  28. McNaughton AL, Lourenço J, Bester PA, Mokaya J, Lumley SF, Obolski U et al. Hepatitis B virus seroepidemiology data for Africa: Modelling intervention strategies based on a systematic review and meta-analysis. PLoS Med. 2020;17(4):e1003068. PubMed | Google Scholar

  29. Anarfi JK. Universities and HIV/AIDS in Sub Saharan Africa: A Case Study of the University of Ghana, Legon. ADEA Working Group on Higher Education, New York City: The World Bank. 2000. Google Scholar

  30. Awofala AA, Ogundele OE. HIV epidemiology in Nigeria. Saudi J Biol Sci. 2018;25(4):697-703. PubMed | Google Scholar

  31. Gayle HD, Keeling RP, Garcia-Tunon M, Kilbourne BW, Narkunas JP, Ingram FR et al. Prevalence of the human immunodeficiency virus among university students. N Engl J Med. 1990;323(22):1538-1541. PubMed | Google Scholar

  32. De Beer IH, Gelderblom HC, Schellekens O, Gaeb E, Van Rooy G, McNally A et al. University students and HIV in Namibia: an HIV prevalence survey and a knowledge and attitude survey. J Int AIDS Soc. 2012;15(1):9. PubMed | Google Scholar

  33. Mengistu B. HIV prevalence and associated factors among university students of Dire Dawa University, eastern Ethiopia. Sex Transm Infect. 2013;89:A243.